Cite
Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
MLA
John A. Wagner, and JR Ball. “Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.” Clinical Pharmacology and Therapeutics, vol. 98, no. 1, Apr. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....771331b7da936fdcb664249d790551b8&authtype=sso&custid=ns315887.
APA
John A. Wagner, & JR Ball. (2015). Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Clinical Pharmacology and Therapeutics, 98(1).
Chicago
John A. Wagner, and JR Ball. 2015. “Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.” Clinical Pharmacology and Therapeutics 98 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....771331b7da936fdcb664249d790551b8&authtype=sso&custid=ns315887.